Beacon Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 10, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	23,146	24,463	35,528	56,595	59,667	28,552
Market Cap Growth	-23.34%	-31.14%	-37.22%	-5.15%	108.98%	103.62%
Enterprise Value	29,798	30,968	45,350	62,791	63,025	30,523
Last Close Price	100.20	103.72	148.05	234.30	245.53	116.74
PE Ratio	18.70	25.85	68.19	111.01	63.81	33.08
PS Ratio	1.57	1.95	3.32	6.65	7.44	4.01
PB Ratio	3.10	3.67	5.83	9.53	10.04	5.33
P/TBV Ratio	3.10	3.68	5.86	9.54	10.04	5.33
P/FCF Ratio	31.85	31.42	-	-	-	-
P/OCF Ratio	14.08	15.29	-	91.11	55.14	145.26
EV/Sales Ratio	2.02	2.47	4.24	7.38	7.86	4.29
EV/EBITDA Ratio	8.75	10.44	19.36	41.92	30.64	17.47
EV/EBIT Ratio	10.94	13.27	24.99	64.13	38.97	22.42
EV/FCF Ratio	41.00	39.78	-	-	-	-
Debt / Equity Ratio	1.31	1.53	1.69	1.25	0.64	0.47
Debt / EBITDA Ratio	2.87	3.44	4.41	4.98	1.86	1.43
Debt / FCF Ratio	13.47	13.11	-	-	-	-
Net Debt / Equity Ratio	0.89	1.49	1.64	1.17	0.55	0.40
Net Debt / EBITDA Ratio	1.95	3.36	4.27	4.66	1.60	1.23
Net Debt / FCF Ratio	9.15	12.80	-7.84	-5.85	-5.15	-18.43
Asset Turnover	0.71	0.65	0.64	0.67	0.83	0.91
Inventory Turnover	2.15	1.96	2.14	2.15	2.40	2.99
Quick Ratio	0.67	0.39	0.36	0.36	0.54	0.82
Current Ratio	1.52	1.54	1.37	1.20	1.38	1.87
Return on Equity (ROE)	17.70%	14.84%	8.66%	8.58%	16.55%	17.29%
Return on Assets (ROA)	8.18%	7.61%	6.76%	4.81%	10.45%	10.83%
Return on Invested Capital (ROIC)	12.81%	10.38%	6.84%	6.64%	13.98%	14.31%
Return on Capital Employed (ROCE)	23.20%	21.10%	18.80%	13.70%	26.30%	23.70%
Earnings Yield	5.35%	3.87%	1.47%	0.90%	1.57%	3.02%
FCF Yield	3.14%	3.18%	-3.59%	-2.11%	-1.07%	-0.41%
Dividend Yield	2.10%	2.02%	1.35%	0.68%	0.65%	1.29%
Payout Ratio	-	36.67%	70.93%	72.78%	39.95%	6.88%
Total Shareholder Return	2.12%	2.02%	1.35%	0.68%	0.65%	1.29%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.